Related Experiment Video
Updated: Nov 9, 2025

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
Published on: February 2, 2024
Ribociclib induced acute kidney injury: A case report
Ilkay Gulturk1, Mesut Yilmaz1, Aykut Ozmen1
1Medical Oncology Department, Bakırköy Sadi Konuk Training and Research Hospital, Istanbul, Turkey.
Ribociclib, a CDK4/6 inhibitor for breast cancer, can cause acute kidney injury (AKI). This case report details a patient experiencing severe AKI, leading to permanent discontinuation of ribociclib treatment.
Area of Science:
- Oncology
- Nephrology
- Pharmacology
Background:
- Breast cancer is the most common cancer in women, with HR+ subtype comprising 75% of cases.
- CDK4/6 inhibitors combined with endocrine therapy improve survival in HR+ breast cancer.
- Ribociclib is an oral CDK4/6 inhibitor with identified adverse effects.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care

